⚡
CHARGED ALPHA
Stock Detail
Stock Library / MDGL
MDGL Unclassified Latest YouTube: Q1 2026

MDGL

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest on YouTube Latest Podcast Company Website Back to Library

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q1 2026
Podcast available
Yes
Current price
$517.26
+4.27 (+0.83%)
Trailing / Forward P/E
—
Forward: 41.78x
Market cap / Volume
—
Volume: —
Revenue / Earnings Growth
126.8%
Earnings: -28.9%
Margins
-29.8% op
Gross: 93.1% · Net: -27.3%
Balance sheet
3.50x current
Debt / Equity: 63.9
52-week range / Beta
$265.00 - $615.00
Beta: -1.04
Analyst target
$674.36
Upside: 30.4%
Cash / shareholder return
-1.31% FCF yield
Dividend yield: —

Company context

Industry: Biotechnology
Country: United States
Employees: —
Price to book: 21.93x
Return on equity: -49.4%
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Price chart

Market context for MDGL

Competitive view

MDGL vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

MDGL
MDGL
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
SS&C Technologies Holdings Inc.
SSNC
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Charles Schwab Corporation
SCHW
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
MDGL
$11.93B
MDGL
SSNC
$16.15B
SS&C Technologies Holdings Inc.
SCHW
$156.78B
Charles Schwab Corporation
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
MDGL
—
MDGL
SSNC
20.8x
SS&C Technologies Holdings Inc.
SCHW
17.9x
Charles Schwab Corporation
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
MDGL
41.8x
MDGL
SSNC
8.9x
SS&C Technologies Holdings Inc.
SCHW
12.5x
Charles Schwab Corporation
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
MDGL
126.8%
MDGL
SSNC
8.8%
SS&C Technologies Holdings Inc.
SCHW
15.8%
Charles Schwab Corporation
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
MDGL
-28.9%
MDGL
SSNC
8.3%
SS&C Technologies Holdings Inc.
SCHW
38.6%
Charles Schwab Corporation
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
MDGL
-29.8%
MDGL
SSNC
24.2%
SS&C Technologies Holdings Inc.
SCHW
49.4%
Charles Schwab Corporation
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
MDGL
93.1%
MDGL
SSNC
48.0%
SS&C Technologies Holdings Inc.
SCHW
97.5%
Charles Schwab Corporation
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
MDGL
-27.3%
MDGL
SSNC
12.7%
SS&C Technologies Holdings Inc.
SCHW
38.0%
Charles Schwab Corporation
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
MDGL
-49.4%
MDGL
SSNC
11.8%
SS&C Technologies Holdings Inc.
SCHW
19.1%
Charles Schwab Corporation
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
MDGL
-1.3%
MDGL
SSNC
7.9%
SS&C Technologies Holdings Inc.
SCHW
6.2%
Charles Schwab Corporation
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
MDGL
63.91x
MDGL
SSNC
110.67x
SS&C Technologies Holdings Inc.
SCHW
120.77x
Charles Schwab Corporation
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
MDGL
3.50x
MDGL
SSNC
1.10x
SS&C Technologies Holdings Inc.
SCHW
0.63x
Charles Schwab Corporation
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
MDGL
-1.04
MDGL
SSNC
1.12
SS&C Technologies Holdings Inc.
SCHW
0.80
Charles Schwab Corporation
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
MDGL
—
MDGL
SSNC
1.6%
SS&C Technologies Holdings Inc.
SCHW
1.2%
Charles Schwab Corporation
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
MDGL
30.4%
MDGL
SSNC
41.4%
SS&C Technologies Holdings Inc.
SCHW
28.5%
Charles Schwab Corporation

Episode timeline

Episode archive for MDGL

Each row is one earnings episode with every verified platform link available.

Q1 2026
Episode live
Published youtube podcast complete
MDGL Stock: EPS Beats, Revenue Misses — Q1 2026
Quarterly earnings-analysis entry for MDGL. Use the links on the right to open the video or podcast episode.
YouTube Podcast